Next Article in Journal
Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®
Next Article in Special Issue
Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders
Previous Article in Journal
Purpose-Oriented Antibody Libraries Incorporating Tailored CDR3 Sequences
Previous Article in Special Issue
Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy
 
 
Article

Article Versions Notes

Antibodies 2015, 4(2), 123-140; https://doi.org/10.3390/antib4020123
Action Date Notes Link
article pdf uploaded. 9 June 2015 11:24 CEST Version of Record https://www.mdpi.com/2073-4468/4/2/123/pdf
article html file updated 21 August 2015 13:21 CEST Original file -
article html file updated 26 March 2019 04:25 CET Update -
article html file updated 6 May 2019 18:09 CEST Update -
article html file updated 6 February 2020 19:30 CET Update -
article html file updated 16 July 2022 00:22 CEST Update https://www.mdpi.com/2073-4468/4/2/123/html
Back to TopTop